NCT00183820: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma |
|
|
| Completed | 2 | 30 | US | paclitaxel, gemcitabine, and oxaliplatin | University of Southern California, Sanofi | Testicular Cancer, Germ Cell Neoplasm | 12/15 | 08/16 | | |